4-(4-bromophenyl)tetrahydro-2H-1,2-thiazine 1,1-dioxide | 133778-14-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻嗪类
• 英文名称: 4-(4-bromophenyl)tetrahydro-2H-1,2-thiazine 1,1-dioxide
• 英文别名: 4-(4-Bromophenyl)-1,1-dioxotetrahydro-1,2-thiazine；4-(4-bromophenyl)thiazinane 1,1-dioxide
• CAS: 133778-14-0
• 化学式: C₁₀H₁₂BrNO₂S
• 分子量: 290.181
• InChiKey: QPJDUOGIWOHBDZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  54.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(4-bromophenyl)tetrahydro-2H-1,2-thiazine 1,1-dioxide 在 四氢呋喃 、 bis-triphenylphosphine-palladium(II) chloride 、 sodium hydroxide 、 copper(l) iodide 、 硼烷 、 双氧水 、 三乙胺 作用下， 以 苯 为溶剂， 反应 2.92h， 生成 4-(tetrahydro-2H-1,2-thiazin-4-yl)benzeneacetic acid S,S-dioxide
  参考文献：
  名称：

  Vinyl sulfonyl esters and amides in the synthesis of substituted .delta.-sultams and .delta.-sultones

  摘要：

  The Michael reaction of phenyl vinyl sulfonate (3) or vinyl sulfonamide 12 with phenylacetic esters was the key step in a general synthesis of 4-phenyl-substituted 1,2-thiazane, 1,1-dioxides (sultams) and 5-phenyl-1,2-oxathiane 1,1-dioxides (sultones). This methodology was applied to the synthesis of some cyclic sulfonamide and sulfonate derivatives (I and II) of the potent TXA2 receptor antagonists BM.13177 and BM.13505.

  DOI：

  10.1021/jo00011a020
• 作为产物：
  描述：

  methyl α-<2-<amino>sulfonyl>ethyl>-4-bromobenzeneacetate 在 sodium tetrahydroborate 、 Ce(NH₄)NO₃ 、 水 、 sodium hydride 、 三氟乙酸 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 乙腈 为溶剂， 生成 4-(4-bromophenyl)tetrahydro-2H-1,2-thiazine 1,1-dioxide
  参考文献：
  名称：

  Vinyl sulfonyl esters and amides in the synthesis of substituted .delta.-sultams and .delta.-sultones

  摘要：

  The Michael reaction of phenyl vinyl sulfonate (3) or vinyl sulfonamide 12 with phenylacetic esters was the key step in a general synthesis of 4-phenyl-substituted 1,2-thiazane, 1,1-dioxides (sultams) and 5-phenyl-1,2-oxathiane 1,1-dioxides (sultones). This methodology was applied to the synthesis of some cyclic sulfonamide and sulfonate derivatives (I and II) of the potent TXA2 receptor antagonists BM.13177 and BM.13505.

  DOI：

  10.1021/jo00011a020

文献信息

• (BIS)sulfonamide derivatives
  申请人：——

  公开号：US20040054009A1

  公开（公告）日：2004-03-18

  The present invention provides (bis) sulfonamide derivatives of formula (I) useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

  本发明提供了公式(I)的(双)磺胺衍生物，可用于增强哺乳动物的谷氨酸受体功能，因此可用于治疗多种疾病，如精神疾病和神经系统疾病。
• Sulphonamide derivatives
  申请人：——

  公开号：US20020002158A1

  公开（公告）日：2002-01-03

  Glutamate receptor function in a mammal may be potentiated using an effective amount of a compound of formula R 1 —L—NHSO 2 R 2 I in which R 1 represents an unsubstituted or substituted aromatic or heteroaromatic group; R 2 represents (1-6C)alkyl, (3-6C)cycloalkyl, (1-6C)fluoroalkyl, (1-6C)chloroalkyl, (2-6C)alkenyl, (1-4C)alkoxy(1-4C)alkyl, phenyl which is unsubstituted or substituted by halogen, (1-4C)alkyl or (1-4C)alkoxy, or a group, of formula R 3 R 4 N in which R 3 and R 4 each independently represents (1-4C)alkyl or, together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, piperidinyl, morpholino, piperazinyl, hexahydroazepinyl or octahydroazocinyl group; and L represents a (2-4C)alkylene chain which is unsubstituted or substituted by one or two substituents selected independently from (1-6C)alkyl, aryl(1-6C)alkyl, (2-6C)alkenyl, aryl(2-6C)alkenyl and aryl, or by two substituents which, together with the carbon atom or carbon atoms to which they are attached form a (3-8C)carbocyclic ring; and pharmaceutically acceptable salts thereof. Also disclosed are novel compounds of formula I, processes for preparing them and pharmaceutical compositions containing them.

  一种具有公式R1-L-NHSO2R2的化合物的有效量可以增强哺乳动物中的谷氨酸受体功能，其中R1表示未取代或取代的芳香或杂环芳香基团；R2表示（1-6C）烷基，（3-6C）环烷基，（1-6C）氟烷基，（1-6C）氯烷基，（2-6C）烯基，（1-4C）烷氧基（1-4C）烷基，苯基，该苯基未取代或通过卤素，（1-4C）烷基或（1-4C）烷氧基取代，或公式R3R4N的基团，其中R3和R4各自独立地表示（1-4C）烷基，或者与它们所连接的氮原子一起形成一个氮杂环基团，包括氮杂丙环基团，吡咯环基团，哌啶环基团，吗啉环基团，哌嗪环基团，六氢氮杂环基团或八氢氮杂环基团；L表示未取代或通过（1-6C）烷基，芳基（1-6C）烷基，（2-6C）烯基，芳基（2-6C）烯基和芳基中选择的一种或两种独立选择的取代基取代的（2-4C）烷基链，或者通过两种取代基与它们所连接的碳原子或碳原子一起形成一个（3-8C）碳环；以及其药学上可接受的盐。还公开了公式I的新化合物，制备它们的过程以及包含它们的制药组合物。
• Aza-quinolinol phosphonate integrase inhibitor compounds
  申请人：Jin Haolun

  公开号：US20050137199A1

  公开（公告）日：2005-06-23

  Aza-quinolinol phosphonate compounds and methods for inhibition of HIV-integrase are disclosed. Ar is aryl or heteroaryl connecting R 6 to L. L is a bond or a linker connecting a ring atom of Ar to N. The ring atoms, X 1 -X 5 may be N, substituted nitrogen, or substituted carbon, and form rings. The compounds include at least one phosphonate group covalently attached at any site.

  本发明公开了Aza-quinolinol磷酸酯化合物及其抑制HIV整合酶的方法。其中，Ar是芳基或杂芳基，连接R6到L。L是一个键或连接Ar的环原子到N的连接体。环原子X1-X5可以是N、取代氮或取代碳，并形成环。该化合物至少包括一个磷酸酯基固定在任何一个位点上。
• Pyrimidyl phosphonate antiviral compounds and methods of use
  申请人：Jin Haolun

  公开号：US20050282839A1

  公开（公告）日：2005-12-22

  Pyrimidine I and pyrimidinone II phosphonate compounds and methods for viral inhibition are disclosed. The compounds include at least one phosphonate group covalently attached at any site.

  本发明揭示了嘧啶I和嘧啶酮II膦酸酯化合物及其用于病毒抑制的方法。这些化合物包括至少一个膦酸酯基固定在任何位置上。
• Phosphonate analogs of HIV integrase inhibitor compounds
  申请人：Cai R. Zhenhong

  公开号：US20060116356A1

  公开（公告）日：2006-06-01

  Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

  本发明揭示了至少具有一个膦酸酯基团的新型HIV整合酶抑制剂化合物，其保护中间体以及用于抑制HIV整合酶的方法。